| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 09/03/2026 | ±4.3% | +1.4% | over-priced |
| 06/04/2026 | ±3.2% | -0.9% | over-priced |
| 09/04/2025 | ±2.7% | +3.8% | under-priced |
| 06/05/2025 | ±2.8% | -1.3% | over-priced |
| 12/05/2024 | ±2.7% | +0.7% | over-priced |
| 08/29/2024 | ±2.8% | +0.1% | over-priced |
| 06/05/2024 | ±2.9% | +0.5% | over-priced |
| 12/07/2023 | ±2.7% | +0.9% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2027 | $2.92 | $2.4B | $329M |
| Q1 FY2027 | $1.69 | $2.5B | $195M |
| Q2 FY2026 | $3.10 | $2.5B | $371M |
| Q1 FY2026 | $2.60 | $2.4B | $315M |
lululemon athletica inc. (LULU) reports in 150 days, with the next report estimated for 02/09/2027. Across the last 8 reports, options priced an average ±3.0% earnings move while the stock actually moved 1.2% on average — the market has systematically over-priced LULU's earnings risk. Fundamentals into the print: EPS down 52.1% year-over-year, revenue down 33.1%. QuantLogix's live 5-factor engine currently reads LULU as a buy at 57/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →